Breaking News on Laboratory Equipment

Video season's greetings from Decision News Media

22-Dec-2008 - The Decision News Media team would like to bring you its seasonal greetings in person and show you around the offices.

Qiagen buys Biosystems business from Biotage

13-Oct-2008 - Dutch sample and assay technology expert Qiagen has continued its march into the detection system market with the acquisition of Biotage’s Biosystems business.

Bio-Quant expands animal diagnostic services

09-Oct-2008 - San Diego-based biotechnology contract research organisation (CRO) Bio-Quant has expanded its animal diagnostic services offering to cover all nine species used in medical research.

GE Healthcare turns up heat on interactions with MicroCal buy

05-Oct-2008 - GE Healthcare has bought label-free molecular interaction analysis expert MicroCal to bolster its label-free analysis offering to life science and pharmaceutical customers.

Invitrogen and ABI unveil new company structure

19-Sep-2008 - Despite the credit crunch, Invitrogen’s acquisition of ABI (Applied Biosystems) is expected to be complete by early November and details of how the merged entity will be structured have just been released.

Charles River expands Discovery Services

17-Sep-2008 - Charles River Laboratories has agreed to buy US-based drug discovery imaging expert Molecular Imaging Research, Inc. (MIR) for approximately $12.5m (€8.8m) in cash.

Tripos looks to the future with Pharsight acquisition

11-Sep-2008 - Drug discovery informatics and services provider, Tripos International, has agreed to buy Pharsight Corporation, a provider of software and strategic services for clinical drug development.

MDS struggles as Pharma Services' revenue drops

09-Sep-2008 - Beleaguered life science tools and services company MDS Inc, has recorded disappointing third quarter results, with revenues from its Analytical Technologies and MDS Pharma Services divisions missing forecasts.

New investment to help Quotient grow even faster

08-Sep-2008 - UK analytical services expert, Quotient Bioscience has received a significant equity investment from TA Associates to help further the firm’s acquisition-led and organic growth strategy.

Agilent’s life science sales grow as profits drop

22-Aug-2008 - Agilent recorded strong third quarter revenue growth for its Bio-Analytical segment, which was tempered by the stagnation of income from its Electronic Measurement division.

Bruker ‘forces’ its way into the AFM market

22-Aug-2008 - Bruker’s X-ray diffraction (XRD) division, Bruker AXS, has agreed to buy German atomic force microscope (AFM) manufacturer S.I.S. Surface Imaging Systems.

Qiagen records strong revenue growth in Q2

18-Aug-2008 - Dutch assay experts Qiagen reported a 61 per cent jump in revenues helped by its $1.6bn (€1.07bn) acquisition of Digene towards the end of last year.

Bio-Rad’s revenues and profits soar

18-Aug-2008 - Bio-Rad has reported second-quarter revenue growth of 33 per cent due to its acquisition of laboratory diagnostics firm DiaMed and strong organic growth.

IDT looks to transform European oligo market

08-Aug-2008 - Integrated DNA Technologies (IDT) has completed the expansion of its European production facility, enabling the company to supply its European customers faster than ever before.

Bruker achieves strong revenue growth

08-Aug-2008 - Bruker recorded a 31 per cent increase in revenue for the second quarter, marking a strong start after it acquired its affiliated Bruker BioSpin in February for $914m.

Veeco exceeds expectations despite poor AFM sales

08-Aug-2008 - Veeco Instruments returned to profitability with the company’s ‘best quarterly performance in two years’ even though its metrology unit struggled due to weakness in the semiconductor market.

Invitrogen and ABI post strong results

04-Aug-2008 - Invitrogen’s plans to buy Applied Biosystems (ABI) are on track with US antitrust regulators approving the deal and both firms achieving strong revenue growth.

Affymetrix slumps as pharma sales fall

31-Jul-2008 - Affymetrix slumped to an operating loss in the second quarter of 2008, reporting flat revenues and blaming a 30 per cent reduction in sales to the pharmaceutical sector.

PerkinElmer goes from strength to strength

31-Jul-2008 - Robert Friel’s tenure as CEO of PerkinElmer continued its strong start with the firm reporting a 21 per cent increase in second quarter revenues compared to the same period last year.

Thermo buys Affinity BioReagents

25-Jul-2008 - Thermo Fisher Scientific has followed up its acquisition of Open Biosystems with the purchase of antibody experts Affinity BioReagents to further bolster its protein research offering.

Medtox sees dip in clinical lab services, but profits rise

24-Jul-2008 - Laboratory services and diagnostics company Medtox Scientific has posted a healthy hike in operating profits for the second quarter, despite a challenging operating environment that pegged back sales growth.

Lab suppliers post solid Q2 growth despite the credit crisis

24-Jul-2008 - With fears of a global recession riding on the back of the credit crisis, many laboratory suppliers have managed to weather the storm and still achieve double digit sales growth in the second quarter of 2008.

Weekly comment

Globalisation of advanced R&D services 'on the rise'

17-Jul-2008 - Pharmaceutical companies in the developed world have already shifted substantial manufacturing and clinical trial work to emerging economies such as China and India, but a new study suggest they are increasingly counting on these countries for advanced research and development services as well.

FDA launches QbD pilot programme

15-Jul-2008 - The US Food and Drug Administration (FDA) is launching a quality-by-design (QbD) pilot programme for biotechnology submissions.